60 related articles for article (PubMed ID: 21697278)
21. HLA-G in B-chronic lymphocytic leukaemia: clinical relevance and functional implications.
Rebmann V; Nückel H; Dührsen U; Grosse-Wilde H
Semin Cancer Biol; 2007 Dec; 17(6):430-5. PubMed ID: 17683947
[TBL] [Abstract][Full Text] [Related]
22. Baxbeta: a constitutively active human Bax isoform that is under tight regulatory control by the proteasomal degradation mechanism.
Fu NY; Sukumaran SK; Kerk SY; Yu VC
Mol Cell; 2009 Jan; 33(1):15-29. PubMed ID: 19150424
[TBL] [Abstract][Full Text] [Related]
23. Direct identification of human tumor-associated peptide antigens and a preclinical model to evaluate their use.
Engelhard VH; Bullock TN; Colella TA; Mullins DW
Cancer J; 2000 May; 6 Suppl 3():S272-80. PubMed ID: 10874498
[TBL] [Abstract][Full Text] [Related]
24. Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
Bellone S; Anfossi S; O'Brien TJ; Cannon MJ; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
Cancer; 2009 Feb; 115(4):800-11. PubMed ID: 19117353
[TBL] [Abstract][Full Text] [Related]
25. Is immune escape via human leukocyte antigen expression clinically relevant in chronic lymphocytic leukemia? Focus on the controversies.
Guillaume N; Marolleau JP
Leuk Res; 2013 Apr; 37(4):473-7. PubMed ID: 23347904
[TBL] [Abstract][Full Text] [Related]
26. The E3 ubiquitin ligase TRIM17 promotes gastric cancer survival and progression via controlling BAX stability and antagonizing apoptosis.
Shen J; Yang H; Qiao X; Chen Y; Zheng L; Lin J; Lang J; Yu Q; Wang Z
Cell Death Differ; 2023 Oct; 30(10):2322-2335. PubMed ID: 37697039
[TBL] [Abstract][Full Text] [Related]
27. Synthetic Peptides with Inadvertent Chemical Modifications Can Activate Potentially Autoreactive T Cells.
Man S; Redman JE; Cross DL; Cole DK; Can I; Davies B; Hashimdeen SS; Reid R; Llewellyn-Lacey S; Miners KL; Ladell K; Lissina A; Brown PE; Wooldridge L; Price DA; Rizkallah PJ
J Immunol; 2021 Aug; 207(4):1009-1017. PubMed ID: 34321228
[TBL] [Abstract][Full Text] [Related]
28. Optimized Peptide-MHC Multimer Protocols for Detection and Isolation of Autoimmune T-Cells.
Dolton G; Zervoudi E; Rius C; Wall A; Thomas HL; Fuller A; Yeo L; Legut M; Wheeler S; Attaf M; Chudakov DM; Choy E; Peakman M; Sewell AK
Front Immunol; 2018; 9():1378. PubMed ID: 30008714
[TBL] [Abstract][Full Text] [Related]
29. Extracellular Vesicle Subtypes Released From Activated or Apoptotic T-Lymphocytes Carry a Specific and Stimulus-Dependent Protein Cargo.
Tucher C; Bode K; Schiller P; Claßen L; Birr C; Souto-Carneiro MM; Blank N; Lorenz HM; Schiller M
Front Immunol; 2018; 9():534. PubMed ID: 29599781
[TBL] [Abstract][Full Text] [Related]
30. Peptide-MHC Class I Tetramers Can Fail To Detect Relevant Functional T Cell Clonotypes and Underestimate Antigen-Reactive T Cell Populations.
Rius C; Attaf M; Tungatt K; Bianchi V; Legut M; Bovay A; Donia M; Thor Straten P; Peakman M; Svane IM; Ott S; Connor T; Szomolay B; Dolton G; Sewell AK
J Immunol; 2018 Apr; 200(7):2263-2279. PubMed ID: 29483360
[TBL] [Abstract][Full Text] [Related]
31. CRISPR-mediated TCR replacement generates superior anticancer transgenic T cells.
Legut M; Dolton G; Mian AA; Ottmann OG; Sewell AK
Blood; 2018 Jan; 131(3):311-322. PubMed ID: 29122757
[TBL] [Abstract][Full Text] [Related]
32. DRAM1 regulates apoptosis through increasing protein levels and lysosomal localization of BAX.
Guan JJ; Zhang XD; Sun W; Qi L; Wu JC; Qin ZH
Cell Death Dis; 2015 Jan; 6(1):e1624. PubMed ID: 25633293
[TBL] [Abstract][Full Text] [Related]
33. Antibody stabilization of peptide-MHC multimers reveals functional T cells bearing extremely low-affinity TCRs.
Tungatt K; Bianchi V; Crowther MD; Powell WE; Schauenburg AJ; Trimby A; Donia M; Miles JJ; Holland CJ; Cole DK; Godkin AJ; Peakman M; Straten PT; Svane IM; Sewell AK; Dolton G
J Immunol; 2015 Jan; 194(1):463-74. PubMed ID: 25452566
[TBL] [Abstract][Full Text] [Related]
34. CD8
Reid RA; Redman JE; Rizkallah P; Fegan C; Pepper C; Man S
Immunology; 2014 Oct; 144(3):495-505. PubMed ID: 25284607
[TBL] [Abstract][Full Text] [Related]
35. Comparison of peptide-major histocompatibility complex tetramers and dextramers for the identification of antigen-specific T cells.
Dolton G; Lissina A; Skowera A; Ladell K; Tungatt K; Jones E; Kronenberg-Versteeg D; Akpovwa H; Pentier JM; Holland CJ; Godkin AJ; Cole DK; Neller MA; Miles JJ; Price DA; Peakman M; Sewell AK
Clin Exp Immunol; 2014 Jul; 177(1):47-63. PubMed ID: 24673376
[TBL] [Abstract][Full Text] [Related]
36. Antitumor activity of celastrol nanoparticles in a xenograft retinoblastoma tumor model.
Li Z; Wu X; Li J; Yao L; Sun L; Shi Y; Zhang W; Lin J; Liang D; Li Y
Int J Nanomedicine; 2012; 7():2389-98. PubMed ID: 22661892
[TBL] [Abstract][Full Text] [Related]
37. A novel tumor antigen derived from enhanced degradation of bax protein in human cancers.
Nunes CT; Miners KL; Dolton G; Pepper C; Fegan C; Mason MD; Man S
Cancer Res; 2011 Aug; 71(16):5435-44. PubMed ID: 21697278
[TBL] [Abstract][Full Text] [Related]
38. Gene expression profiling identifies BAX-delta as a novel tumor antigen in acute lymphoblastic leukemia.
Maia S; Haining WN; Ansén S; Xia Z; Armstrong SA; Seth NP; Ghia P; den Boer ML; Pieters R; Sallan SE; Nadler LM; Cardoso AA
Cancer Res; 2005 Nov; 65(21):10050-8. PubMed ID: 16267031
[TBL] [Abstract][Full Text] [Related]
39. Abnormal intracellular level of Bax in CD3+ cells from untreated B-cell chronic lymphocytic leukemia patients.
Scamardella F; Maconi M; Albertazzi L; Gamberi B; Gugliotta L; Brini M
Lab Hematol; 2006; 12(4):187-92. PubMed ID: 17118768
[TBL] [Abstract][Full Text] [Related]
40. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
